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Estimating equivalent cutoff thresholds for drugs in blood 
and oral fluid using prevalence regression: A study of 
tetrahydrocannabinol and amphetamine 
 
A B S T R A C T 
 
Aim: To validate a method for determining equivalent drug cutoff concentrations for 
tetrahydrocannabinol and amphetamine in blood and oral fluid, which ensures that the drug 
prevalence in samples of blood and oral fluid taken simultaneously is equal. 
Methods: A method using regression analysis of drug concentrations for defined percentiles in 
blood and oral fluid was developed. The accuracy and precision of this technique was 
investigated. As study populations, 311 cannabis users and 197 amphetamine users from the 
Rosita-2 Project were used.  
Results: A total of 80 paired oral fluid and blood concentrations were needed to determine 
accurate regression formulae. When using the formulae to calculate drug cutoff 
concentrations in oral fluid corresponding to 2.0, 4.0, 6.0, 8.0 and 10.0 ng/ml 
tetrahydrocannabinol in blood and 200, 400, 600, 800 and 1000 ng/ml amphetamine in blood, 
the accuracy was better than 100±20% compared to actual prevalence in blood with precision 
better than ±20%. 
Conclusion:  Prevalence regression may be a useful tool in estimating equivalent cutoff 
concentrations in blood and oral fluid. 
 
Keywords: amphetamine; tetrahydrocannabinol; cutoff concentrations; blood; oral fluid; 
prevalence. 
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1. Introduction 
The collection and analysis of oral fluid has become a valuable tool in epidemiological studies 
of alcohol and drug use. Oral fluid reflects better than urine whether a subject has recently 
used alcohol or drugs and reflects whether or not the substance of interest is present in the 
blood. For most drugs the concentration in oral fluid cannot be used to accurately estimate the 
drug concentration in blood for an individual because of large inter-individual variations in 
oral fluid to blood (OF/B) concentration ratios [1]; the relationship is merely semi-
quantitative. However, in a population of drug users, the distribution of drug concentrations in 
oral fluid and the average and median drug concentrations in oral fluid is related to the 
distribution of drug concentrations in blood samples from that population, including the 
average and median concentrations. Individual variations will affect the drug concentration 
distribution and average less if the population size is large, similar to the fact that the standard 
error of a mean is small if the sample size is large. 
 
In some cross-sectional studies of drug use, participants were asked to provide a blood 
sample, and those who objected were asked to provide a sample of oral fluid [2,3]. In those 
studies, analytical results from blood and oral fluid samples were used to calculate the overall 
prevalence of drug use. In that type of studies, useful calculations of prevalence can only be 
performed if equivalent drug cutoff concentrations are used for blood and oral fluid. 
 
Case-control studies should ideally be performed by using the same type of biological 
specimen for both cases and control. However, that may be difficult. In some studies, for 
example the Immortal [4] and DRUID [3] studies of alcohol, drugs and traffic accidents, 
samples of blood were collected from cases and oral fluid from controls. Equivalent cutoff 
thresholds must also be used in that type of studies to compare prevalence among cases and 
controls and to obtain sound estimations of odds ratio for involvement in traffic accidents 
after having used different types of drugs.  
 
The use of equivalent cutoff concentrations in blood and oral fluid implies that both 
specimens would, on average, be positive for a drug for the same length of time after intake. 
In addition, the prevalence of positive drug findings (i.e., concentration above the cutoff 
threshold) in samples of oral fluid would reflect the prevalence of positive drug findings in 
blood samples.  
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We have previously found that equivalent cutoff concentrations in blood and oral fluid for 
amphetamine and THC may be roughly estimated by multiplying the cutoff concentration in 
blood with the mean or median OF/B ratio or with the slope of a linear regression curve 
(regression coefficient) [5]. A second possibility was to use a mathematical simulation [5], 
which is a more challenging procedure. However, accurate estimations were not observed for 
drug prevalences in blood below 15%.  
 
The aim of this investigation was to describe and validate a novel method for estimating 
equivalent drug cutoff concentrations in blood and oral fluid which is expected to be more 
accurate than using the mean or median OF/B ratio or regression coefficient between 
concentrations in OF and blood. Populations of tetrahydrocannabinol or amphetamine users 
were used for this purpose. 
2. Materials and Methods 
2.1. Study population 
The Rosita-2 Project [6] included drivers who were apprehended by police in seven 
countries suspected for driving under the influence of drugs. Samples of oral fluid were 
collected by using the Intercept Oral Specimen Collection Device (OraSure Technologies, 
Bethlehem PA, USA), and whole blood samples were also obtained. Samples of whole blood 
and oral fluid were analysed by chromatographic-mass spectrometric methods. In some 
countries, the drug concentrations in undiluted oral fluid were calculated by using the average 
dilution factor, in other countries by determining the dilution for each single sample by 
weighing the samples. Analytical findings have been presented elsewhere [1,6]. 
 
All drivers who tested positive for THC or amphetamine in samples of oral fluid, and from 
whom results for analysis of THC and amphetamine in blood were available, were selected 
for this study.  
2.2. Analytical method 
Samples of oral fluid were analysed by different laboratories using different methods based on 
gas chromatography or high-performance liquid chromatography, both with mass 
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spectrometric detection. References to the employed methods have been presented elsewhere 
[1].  
2.3. Prevalence regression 
Mathematical models describing the regression between concentration percentiles in oral fluid 
(response variable) in a population of drug-positive individuals as a function of the 
corresponding concentration percentiles in blood (predictor variable) were determined as 
follows: the drug concentrations in oral fluid corresponding to the 10th, 20th, 30th etc. to the 
90th percentile of the concentrations found among drug-positive samples were plotted against 
the drug concentrations in blood corresponding to the same percentiles. The regression curve 
HTXDWLRQVZHUHGHWHUPLQHGXVLQJWKH³WUHQGOLQH´IXQFWLRQLQ0LFURVRIW([FHO7KHUHJUHVVLRQ
formulae obtained described the relationship between equivalent concentration percentiles in 
oral fluid and blood. Thus, the prevalence (or percentile) of drug concentrations above a given 
cutoff threshold in blood would be equal to the prevalence of drug concentrations in oral fluid 
above a concentration calculated by using the regression formulae.  
 
To determine how well the formulae fitted the original data, the prevalences of drug 
concentrations above estimated cutoff thresholds in oral fluid were compared with the 
prevalences of drug concentrations above the corresponding cutoff thresholds in blood. 
 
To determine how many samples of oral fluid and blood was needed to obtain accurate and 
precise determinations of equivalent cutoff thresholds, 20, 40, 60 and 80 paired samples were 
VHOHFWHGDWUDQGRPXVLQJ0LFURVRIW([FHO¶VUDQGRPIXQFWLRQVL[WLPHVIURPHDFKRIWKe 
populations of amphetamine and cannabis users, regression formulae were determined, and 
cutoff concentrations in oral fluid that were equivalent to the chosen cutoff concentrations in 
blood were calculated. Estimated prevalence was compared with actual prevalence in blood. 
Inaccuracy and precision within ±25% was regarded as acceptable. 
3. Results 
Tetrahydrocannabinol (THC) was found in samples of oral fluid from 311 individuals. 
Individual concentration data for THC in oral fluid are plotted against the corresponding 
FRQFHQWUDWLRQLQEORRGLQ)LJXUHWRS3HDUVRQ¶VFRUUHODWLRQFRHIILFLHQWEHWZHHQLQGLYLGXDO
concentrations in oral fluid versus blood was 0.46, R2=0.21. 
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The median THC concentrations in oral fluid among subjects with blood THC concentrations 
in the ranges <5, 5-9, 10-14 and 15-22 ng/ml were 17, 96, 158 and 275 ng/ml, respectively.  
 
The concentrations in oral fluid corresponding to the 10th percentile, the 20th percentile, and 
so forth until the 90th percentile are plotted against the concentrations of the corresponding 
percentiles in blood in Figure 1 (bottom).  
 
The best fitting regression curves were obtained using either a quadratic curve passing 
through the origin or a power curve. The formula for the quadratic curve function was 
COF=1Â&B2+7.98, where COF=concentration in oral fluid, and CB =concentration in blood. 
The correlation coefficient was very good, R2=0.9998. The formula for the power-function 
was COF Â&B1.40, and the correlation coefficient was also good, R2=0.9952. Both the 
quadratic and power curves are presented in Figure 1. 
 
<Figure 1 about here> 
 
Amphetamine was found in samples of oral fluid from 197 individuals. Individual 
FRQFHQWUDWLRQGDWDDUHSUHVHQWHGLQ)LJXUHWRS3HDUVRQ¶VFRUUHODWLRQFRHIILFLHQWEHtween 
individual concentrations in oral fluid versus blood was 0.53, R2=0.28. The median 
amphetamine concentrations in oral fluid for subjects with blood concentrations in the ranges 
<500, 501-1000, 1001-1500, and 1501-2800 ng/ml were 1915, 9140, 19122 and 23631 ng/ml, 
respectively. 
 
The percentile data for the same individual values are presented in Figure 2 (bottom). The 
formula for the best fitting quadratic regression curve was COF=0.0088 ÂCB2+8.76, where 
COF=concentration in oral fluid, and CB =concentration in blood. The regression coefficient 
was good, R2=0.9973. The formula for the power-function was COF Â&B1.34, and the 
correlation coefficient was also good, R2=0.9923. Both the quadratic and power curves are 
presented in Figure 2. 
 
<Figure 2 about here> 
 
The best fitting regression formulae were used to calculate the drug concentration thresholds 
in oral fluid that were equivalent to blood concentrations of amphetamine of 200, 400, 600, 
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800 and 1000 ng/ml, and THC of 2.0, 4.0, 6.0, 8.0 and 10.0 ng/ml. The estimated prevalence 
obtained when using the calculated cutoff thresholds in oral fluid were compared with actual 
values in blood samples. Results are presented in Table 1 and show that the power and 
quadratic regression curves matched the prevalence in blood for the studied populations very 
well; for THC the quadratic function seemed to be slightly better. 
 
<Table 1 about here> 
 
A study was performed to determine the number of individual data required to obtain 
regression formulae which gave precision and accuracy within ±25%, which was regarded as 
acceptable. From the original populations of amphetamine and THC users, 20, 40, 60 and 80 
subjects were selected at random, and the drug concentrations in oral fluid and blood were 
used to calculate quadratic and power regression formulae. Those formulae were used to 
estimated prevalence based on data for oral fluid and compared with actual data for blood for 
the complete populations. Results are presented in Table 2. When reducing the number of 
samples from 311 for THC or 197 for amphetamine to 20-80, power functions gave better 
correlation than quadratic functions. However, data from 60 and 80 persons were needed to 
obtain reliable regression formulae for amphetamine and THC, respectively. The accuracy 
and precision were then equal to or better than ±25% for estimating prevalence above cutoff 
concentrations in blood equal to or below 1000 ng/ml for amphetamine and 10 ng/ml for 
THC, when using data from 80 persons the accuracy and precision was better than ±20% for 
both substances.  
 
<Table 2 about here> 
4. Discussion 
There is a correlation between drug concentration in oral fluid and blood from drugs of abuse 
[1]. This correlation implies that there also will be a correlation between the drug prevalence 
in oral fluid samples and the prevalence in blood samples from a selected population.  
 
THC and amphetamine were chosen as drugs to be studied only because of large numbers of 
paired data on drug concentrations in oral fluid and blood were available from the Rosita-2 
study. THC and amphetamine may not be the ideal model substances because of very large 
variations in OF/B ratios between individuals.  
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The concentrations of most drugs in oral fluid are results of transfer from blood which is 
affected by protein binding, oral fluid pH, salivary flow rate, and other factors [7]. For THC 
the situation is be more complex. The transfer of THC from blood to oral fluid seems to be 
low, so the observed THC is mainly due to contamination of the oral cavity after cannabis 
smoking [9]. The THC concentration in oral fluid is therefore correlated with the smoked 
dose and time after smoking and thus with the blood THC concentration through an indirect 
mechanism.  
 
Amphetamine has a pKa close to the pH of oral fluid. Individual variations in oral fluid pH 
affect very much the equilibrium ratio between amphetamine in blood and oral fluid, therefore 
the variation in OF/B ratios is large for amphetamine compared to many other drugs. 
 
It is likely that drugs with less variations in OF/B ratios, e.g. some benzodiazepines, will 
provide regression formulae that are more robust and less dependent on the study population 
than THC and amphetamine. It is also expected that those drugs might not require as many as 
80 paired oral fluid and blood samples to enable the calculation of a good regression curve 
formula. 
 
Quadratic regression models (y = ax2 + bx + c) or power models \ DÂEx) fitted the 
regression data for concentration percentiles of THC and amphetamine in oral fluid versus 
blood better than linear models. We have previously tested the accuracy and precision of 
linear models using the regression coefficient (slope of the linear regression line), average and 
median OF/B ratio, and found that those procedures gave acceptable accuracy only for limited 
concentration ranges [5].  
 
A comparison of the quadratic and power regression model with those obtained using the 
average and median OF/B ratios is presented in Figure 3. When plotting the regression curves 
for models using average or median OF/B ratios, linear curves that pass through the origin are 
obtained, and the slopes of the curves correspond to the average or median OF/B ratios, 
respectively. As an example, the figure illustrates that for amphetamine, cutoff concentrations 
in the range from about 50 to 450 ng/ml in blood are approximately equivalent to cutoff 
concentrations in oral fluid equal to the cutoff concentration in blood multiplied with the 
median OF/B ratio. However, for a cutoff concentration in blood of about 800 ng/ml, 
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multiplying with the average OF/B ratio would give a better approximation for the equivalent 
cutoff concentration in oral fluid. This is in accordance with our earlier findings [5].  
 
The quadratic or power regression curves obtained by regression analysis of concentration 
percentiles in blood and oral fluid gave thus accurate estimations of equivalent cutoff 
concentrations in oral fluid for wider concentration ranges than when using linear curves for 
both amphetamine and THC. It cannot be excluded that linear regression curves may be 
obtained for other drugs. We have done some studies of mathematically simulated blood drug 
concentration distributions and found that linear regression lines can be obtained for drugs 
where the OF/B ratios are approximately normally distributed (i.e., bell-shaped Gaussian 
curves) and the OF/B ratios are independent of the drug concentration (H. Gjerde, 
unpublished observations). 
 
<Figure 3 about here> 
 
When comparing the results with our previously proposed method [5], which was based on 
linear regression lines or Monte Carlo simulations with 20 OF/B ratios, the quadratic or power 
curves obtained with prevalence regression were found to give better precisions and 
accuracies. However, a larger number of OF/B data was needed. If increasing the number of 
OF/B ratios when using the average OF/B ratio or the OF/B regression coefficient, the 
accuracy was not improved [5], and increasing the number of OF/B ratios from 20 to 50 
using Monte Carlo simulation did not increase the precision (Gjerde and Verstraete, 
unpublished observations). Thus, the method presented in this report has a potential of giving 
better accuracy and precision than our previous methods, but if limited OF/B data are 
available, our previously proposed methods should be used [5]. 
 
This study has some important limitations. The method for sampling oral fluid may affect the 
drug concentrations found [10] and thus also the regression formulae. The concentration 
might also depend on the population, e.g. heavy amphetamine users may have amphetamine-
induced xerostomia (lack of saliva), which may affect the equilibrium between amphetamine 
concentrations in oral fluid and blood. For THC, the average and median OF/B ratios shortly 
after cannabis smoking might differ from those observed many hours later. Therefore, the aim 
of this report is not to present exact and robust regression formulae that can be used on any 
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other population, but to present a method for determining those formulae for other study 
populations.  
 
The regression formulae presented in this report are valid for the studied populations of 
suspected drugged drivers found to be positive for THC or amphetamine, and probably also 
for similar populations if the sampling of oral fluid is performed with the same type of device. 
When determining a regression formula to estimate equivalent cutoff concentrations in oral 
fluid and blood, we recommend that the formula should be determined by using oral fluid 
samples that are collected from a selection of the population study participants using the same 
type of collection device as in the population study itself or from a similar population.  
 
The data material used in our study was based on samples of oral fluid and blood collected in 
several countries and analysed by several laboratories using different analytical methods. This 
may have introduced some inter-laboratory variation in analytical results [1]. There was in 
some cases a time lapse of more than 30 minutes between sampling of oral fluid and blood, 
and when calculating the drug concentrations in native oral fluid, some laboratories used the 
mean collected volume for the calculation of dilution instead of individual values [1]. These 
issues introduced some additional variation in the results. 
5. Conclusion 
The results indicate that prevalence regression may be used to estimate equivalent cutoff 
thresholds in oral fluid and blood for drug prevalence studies and case-controls studies. 
However, a large number of paired drug concentrations in oral fluid and blood is needed, 
preferably about 80 for THC and amphetamine. 
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F igure 1. Individual concentration data for THC in oral fluid and blood (top) and regression 
DQDO\VLVXVLQJVHOHFWHGSHUFHQWLOHV«WRWKHth percentile; bottom). Regression 
curves: quadratic (²) and power (- - - -). 
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F igure 2. Individual concentration data for amphetamine in oral fluid and blood (top) and 
UHJUHVVLRQDQDO\VLVXVLQJVHOHFWHGSHUFHQWLOHV«XQWLOWKHth percentile; 
bottom). Regression curves: quadratic (²) and power (- - - -). 
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F igure 3. Comparison of regression curves for amphetamine presenting the average OF/B 
ratio (A), median OF/B ratio (M), quadratic (Q) and power regression lines (P). 
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Table 1. Comparison of the actual and estimated prevalence of blood drug concentrations 
above selected cutoffs.  
 
Cutoff (ng/ml) Actual 
prevalence 
(%) 
Quadratic regression model  Power regression model 
Estimated 
prevalence 
(%) 
Accuracy  
(%) 
 Estimated 
prevalence 
(%) 
Accuracy  
(%) 
Amphetamine 
   
   
   
   
   
 
61.4 
39.6 
25.4 
19.3 
12.2 
 
61.9 
41.4 
27.4 
17.3 
12.7 
 
100.8 
103.8 
108.0 
89.5 
104.2 
  
63.5 
39.6 
26.9 
17.3 
12.7 
 
103.3 
100.0 
106.0 
89.5 
104.2 
THC 
   
   
   
   
   
 
59.5 
41.2 
28.0 
20.9 
14.1 
 
58.8 
40.8 
27.7 
21.2 
15.1 
 
98.9 
99.2 
98.9 
101.5 
106.8 
  
57.6 
39.2 
27.0 
21.9 
16.7 
 
96.8 
95.3 
96.6 
104.6 
118.2 
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Table 2. Accuracy (and imprecision as standard deviation, n=6) for the estimation of 
prevalence in blood samples when using different numbers of paired oral fluid and blood 
samples for estimating the prevalence regression equations 
 
Substance and 
cutoff (ng/ml) 
No. of paired oral fluid and blood samples for calculating regression equations 
 20 40 60 80 
Power regression 
models 
    
Amphetamine 
   
   
   
   
   
 
88.1 (58.6) 
73.8 (49.6) 
71.4 (53.2) 
63.2 (59.6) 
75.0 (65.7) 
 
104.4 (6.0) 
102.8 (6.9) 
105.7 (18.5) 
94.3 (24.5) 
103.5 (30.6) 
 
103.2 (7.1) 
104.1 (7.2) 
107.7 (12.5) 
97.8 (16.3) 
110.4 (20.9) 
 
101.9 (2.5) 
199.8 (1.5) 
103.3 (5.0) 
89.0 (7.8) 
97.9 (17.0) 
THC 
   
   
   
   
   
 
99.4 (15.6) 
98.8 (20.6) 
106.7 (27.2) 
110.8 (34.2) 
126.5 (43.3) 
 
93.2 (11.6) 
91.1 (15.7) 
96.9 (18.7) 
96.4 (21.9) 
109.1 (36.5) 
 
93.8 (9.7) 
94.5 (9.6) 
99.6 (11.9) 
104.4 (17.7) 
117.0 (28.6) 
 
96.2 (10.4) 
96.0 (8.3) 
97.7 (3.9) 
102.8 (7.9) 
115.5 (6.6) 
Quadratic 
regression models 
    
Amphetamine 
   
   
   
   
   
 
87.9 (23.4) 
86.5 (12.1) 
89.0 (19.0) 
81.6 (34.3) 
97.9 (46.0) 
 
105.4 (10.6) 
105.8 (14.2) 
104.3 (27.9) 
85.5 (38.6) 
88.2 (45.0) 
 
107.4 (9.9) 
117.3 (20.5) 
110.3 (18.6) 
92.5 (27.0) 
97.2 (36.9) 
 
107.6 (8.0) 
107.1 (5.0) 
106.7 (1.5) 
87.3 (4.0) 
77.8 (33.5) 
THC 
   
   
   
   
   
 
113.1 (35.3) 
109.4 (33.8) 
110.3 (24.2) 
102.3 (24.2) 
102.7 (44.0) 
 
105.0 (28.3) 
102.3 (26.8) 
106.1 (25.2) 
101.3 (22.0) 
104.2 (25.4) 
 
99.7 (34.3) 
103.3 (35.5) 
105.6 (24.3) 
106.4 (17.7) 
114.8 (13.5) 
 
94.3 (11.7) 
96.2 (8.2) 
99.6 (7.2) 
102.3 (11.2) 
113.3 (11.9) 
  
